Evaluation of the effect of carnosine, its novel derivative trolox-carnosine and trolox in a pre-clinical study focussing on the regulation of immunity
European Pharmaceutical Journal · 2016
DOI: 10.1515/afpuc-2016-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Pharmaceutical Journal, 2016. Verfasst von L. Slovák und 5 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The neuroprotective or neurotoxic effects of the products of the kynurenine pathway of tryptophan metabolism highly depend on the action of kynurenine-3-monooxygenase (KMO). The present results show increased concentrations of the KMO in the plasma of rats repeatedly exposed to an immune challenge. Increased concentrations of this key enzyme are likely to cause a shift of kynurenine pathway towards enhanced production of neurotoxic metabolites.
Zitieren
APA
Slovák, L., Poništ, S., Kuncírová, V., Mihalová, D., Fedorova, T., & Bauerová, K. (2016). Evaluation of the effect of carnosine, its novel derivative trolox-carnosine and trolox in a pre-clinical study focussing on the regulation of immunity. European Pharmaceutical Journal. https://doi.org/10.1515/afpuc-2016-0001
Vancouver
Slovák L, Poništ S, Kuncírová V, Mihalová D, Fedorova T, Bauerová K. Evaluation of the effect of carnosine, its novel derivative trolox-carnosine and trolox in a pre-clinical study focussing on the regulation of immunity. European Pharmaceutical Journal. 2016. doi:10.1515/afpuc-2016-0001
BibTeX
@article{Slovk2016,
author = {Slovák, L. and Poništ, S. and Kuncírová, V. and Mihalová, D. and Fedorova, T. and Bauerová, K.},
title = {Evaluation of the effect of carnosine, its novel derivative trolox-carnosine and trolox in a pre-clinical study focussing on the regulation of immunity},
journal = {European Pharmaceutical Journal},
year = {2016},
doi = {10.1515/afpuc-2016-0001}
}
EUVIMED